{"disease":{"id":"patients-with-stage-iv-or-recurrent-adenocarcinoma-of-the-lung","name":"patients with stage iv or recurrent adenocarcinoma of the lung"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02303977","title":"Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}